SAN DIEGO — Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced partnerships with both Google DeepVariant and Sentieon for variant calling analysis. Through the partnerships, the DeepVariant and Sentieon teams have evaluated Element data and generated Element-specific machine learning models. Element will continue to work with both teams to […]
SAN DIEGO — Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Fabric Genomics Inc. to explore commercialization of end-to-end clinical application solutions based on Element’s AVITI system and the Fabric Enterprise clinical interpretation platform. Two initial studies confirmed the ability of the AVITI system to identify […]
SAN DIEGO — Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with 10x Genomics, a life sciences leader focused on mastering biology to advance human health, that demonstrates the seamless integration of the Element AVITI™ System and 10x Genomics’ single cell technologies. 10x Genomics’ Chromium Single Cell and […]
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE AGILENT TARGET ENRICHMENT SOLUTIONS TO EMPOWER CUSTOM AND CATALOG KITS FOR TARGETED SEQUENCING PANELS FOR CUSTOMERS LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a […]
Element Biosciences and Jumpcode Genomics partner to improve next-generation DNA sequencing. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode’s CRISPRclean® technology on Element’s AVITI™ System. The partnership has already demonstrated the value of pairing the technologies, promising improved data quality and […]
SAN DIEGO — Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Dovetail Genomics demonstrating the value and performance of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element’s AVITI System. The ability to unlock access to genomic structure enables cutting-edge science in the fields […]
London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces Dr Annalisa Jenkins, MBBS, FRCP, as Chair of the Board of Directors. Dr Jenkins brings over 30 years of global industry experience to RevoluGen’s board, with expertise in scientific research, genomics, regulatory approval and healthcare systems. She is currently a board […]
Element Biosciences and Agilent Technologies have integrated Element’s AVITI System with Agilent’s SureSelect target enrichment panels. Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Agilent Technologies demonstrating the integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic […]
This partnership integrates the performance, cost, and flexibility of the Element AVITI System with New England Biolabs’ powerful NEBNext Ultra II library prep technology to provide a unique end-to-end solution for Element sequencing customers and further expand the well-established NEBNext Ultra II technology. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, […]
Element Biosciences and QIAGEN partner to validate QIAGEN’s NGS library prep on Element’s AVITI System. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with QIAGEN to validate its leading NGS library prep and target enrichment offerings on the AVITI System. This partnership demonstrates the compatibility of the Element AVITI […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
